Cogstate Ltd (ASX:CGS) Share Price

Company Profile

Business description
Cogstate Ltd is engaged in the creation, validation, and commercialisation of digital brain health assessments and the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its solutions include Digital Cognitive Assessment, Endpoint Data Quality, Remote Assessment and Healthcare Cognitive Screening. Its operating segments are Clinical Trials, Healthcare, and Administration, with Clinical Trials generating maximum revenue. The Group provides licensed software to Clinical Trials and Healthcare customers, comprising access to the software.
Contact
367 Collins Street
Level 32
MelbourneVIC3000
AUS
T: +61 396641300
https://www.cogstate.com
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
Employees
249

Recommended

Strong demand for AI infrastructure drives fair value lift.

Roy Van Keulen | 30 September 2026

Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.

Morningstar | 28 September 2026

Trading at an 18% discount, this wide-moat stock is a rare find.

Malik Ahmed Khan, CFA | 22 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,969.20	82.60	0.93%
CAC 40	7,964.51	71.36	-0.89%
DAX 40	25,199.19	200.02	-0.79%
Dow JONES (US)	50,906.05	443.87	-0.86%
FTSE 100	10,606.00	30.71	-0.29%
HKSE	24,613.27	89.70	0.37%
NASDAQ	26,861.06	63.52	0.24%
Nikkei 225	66,753.72	1,272.45	1.94%
NZX 50 Index	13,834.39	150.76	1.10%
S&P 500	7,651.54	19.30	-0.25%
S&P/ASX 200	8,789.30	80.00	0.92%
SSE Composite Index	3,842.19	11.74	0.31%